Treatment of the pulmonary involvement in the patient with tuberous sclerosis complex.
Roccatello
D
D
Centro Multidisciplinare di Immunopatologia e Documentazione su Malattie Rare (CMID), Presidi Ospedalieri ASL4, sede Osp. Luigi Einaudi, Torino, Italia. cmid@iol.it
Obert
R
R
Sena
G M
GM
Longa
L
L
Rossi
D
D
Grosso
E
E
Cavallo
R
R
Sena
L M
LM
Giachino
O
O
Migone
N
N
D000328:Adult; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D018192:Lymphangioleiomyomatosis / Q000188:drug therapy*; D012097:Repressor Proteins / Q000235:genetics; D014402:Tuberous Sclerosis / Q000150:complications* / Q000235:genetics; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins
D012097:Repressor Proteins; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins